Tomoki Ito
20PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (20)
Sort by Publication Date:
|Aug 19, 2025
Correction: A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia.Hiroki Yamaguchi, Masaki Iino, Shugo Kowata
|May 20, 2025
A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia.Hiroki Yamaguchi, Masaki Iino, Shugo Kowata
|Apr 11, 2025
Correction: Venetoclax treatment for chronic lymphocytic leukemia/small lymphocytic leukemia in Japan: post-marketing surveillance.Tomoki Ito, Tomohiko Kamimura, Toru Kiguchi
|Aug 21, 2024
Venetoclax treatment for chronic lymphocytic leukemia/small lymphocytic leukemia in Japan: post-marketing surveillance.Tomoki Ito, Tomohiko Kamimura, Toru Kiguchi
|May 17, 2024
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.Yutaka Shimazu, Junya Kanda, Yoshiyuki Onda
|Jan 02, 2024
Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study.Masataka Kuwana, Tomoki Ito, Shugo Kowata
Pageof 4
Frequent Collaborators
4 joint publications
Yoshiaki Tomiyama
3 joint publications
Atsushi Satake
2 joint publications
Masaki Iino
2 joint publications
Kenji Yokoyama
2 joint publications
Hiroki Yamaguchi
2 joint publications
Motoaki Shiratsuchi
2 joint publications
Shosaku Nomura
2 joint publications
Masataka Kuwana
2 joint publications
Shugo Kowata
2 joint publications
Katsumichi Fujimaki
